‘Brensis’ attracted interests among other highlighted domestic biosimilars

‘Brensis,’ a biosimilar of MSD and Samsung Bioepis, and its follow-up biosimilars have attracted interests. Since domestic biosimilars have competitiveness in quality and price in the global market of biomedicines which have recorded high growths, it was criticized the supporting role of the government is also essential.

On the 2^nd, the Ministry of Food and Drug Safety held the ‘2015 Policy Fo...